No abstract available
Keywords:
COVID-19; Critical care; Immunomodulatory agents; Pulmonary edema; Respiratory distress syndrome, adult; Therapies, investigational.
MeSH terms
-
Aged
-
Betacoronavirus
-
COVID-19
-
Comorbidity
-
Coronavirus Infections / therapy*
-
Critical Illness / therapy*
-
Female
-
Fibrin Fibrinogen Degradation Products / therapeutic use*
-
Humans
-
Male
-
Middle Aged
-
Pandemics
-
Peptide Fragments / therapeutic use*
-
Pneumonia, Viral / therapy*
-
Respiratory Distress Syndrome / therapy*
-
Respiratory Distress Syndrome / virology
-
SARS-CoV-2
-
Salvage Therapy*
Substances
-
Fibrin Fibrinogen Degradation Products
-
Peptide Fragments
-
fibrinogen Bbeta (15-42)